Cannabidiol/Dronabinol

大麻二酚/四氢大麻酚

Report date: 2026/02/28 20:00:37

Base Information

Drug NameCannabidiol/Dronabinol
Drug Alias Nameelta-9-tetrahydrocannabinol/cannabidiolCannabidiol/tetrahydrocannabinolDelta-9-THC/cannabidiolSmokable marijuanaTetrahydrocannabinol/cannabidiol +[27] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor antagonistsCannabinoid CB2 receptor inverse agonistsCannabinoid receptor agonists
TargetsCannabinoid CB1 receptorCannabinoid CB2 receptorCannabinoid receptor
Therapy Area/IndicationsCorticobasal degenerationAgitationStress Disorders, Post-Traumatic +[58] 
Global Approved IndicationsChronic PainCancer PainNeuralgia +[5] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved Date2005/04/01
Country/TerritoryCzechiaBelgiumBulgaria +[21] 
CombinationsYes DronabinolCannabidiol
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGw Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesCanadian Institutes Of Health Research (Cihr)CNX Therapeutics LtdUniversity Of Manitoba +[14] 
Inactive CompaniesPure GreenGw Pharmaceuticals LtdThe University Of California Davis +[15] 
Active IndicationsCorticobasal degenerationAgitationDepressive Disorder, Major +[30] 
Inactive IndicationsStress Disorders, Post-TraumaticPhobia, SocialPanic Disorder +[28] 

Other Information

ATC CodeN03AX24
Related LinksWikipediaDrugBankKEGG